explore -WSS

explore

author：hotspot 2025-09-03 03:43:45 - browse：664

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： The biotech scorecard for Q1: 17 stock

explore

knowledge

Wikipedia

WSS

Antibiotic resistance and the global rise in human conflict

Teladoc has a new CEO, but challenges remain the same

Medical device trials still don't enroll enough women, study finds

California wildfire smoke linked to 52,000 early deaths, study says

Cheap, fast test for Zika and dengue could cost just $1

Curing rare childhood diseases will falter unless Congress steps up

focus

explore

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Duchenne breakthrough therapy leaves behind pioneering families

Morgan Health, with ambitious aims, wants you to know it’s still here

Cancer drug shortages should be causing more outrage

STAT Virtual Event: ASCO Recap, Live!

In Memoriam: Notable people who died in 2023

ALS patient reclaims some autonomy thanks to wearable 'robot'

Jerome Adams on the need for new antivirals for Covid

Antibiotic resistance and the global rise in human conflict

leisure time

The system is set up to fail children with medical complexity

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Report captures long Covid’s disabling effects and policy challenges

ALS patient reclaims some autonomy thanks to wearable 'robot'

'Essentially witchcraft:' A former naturopath takes on the field

Ahead of JPM, here's who's profiting most in health care

explore

knowledge

Wikipedia

Wikipedia